Search
 
NEWS
 

Phillips Evaluates Second-Line Therapy Options for R/R DLBCL - Targeted Oncology

 
 
During a Targeted Oncology case-based roundtable event, Tycel Phillips, MD, discussed available therapies for a patient with relapsed/refractory diffuse large B-cell lymphoma including CAR T-cell therapy and combination systemic therapies. - READ MORE
By Targeted Oncology
Wed, 14 Dec 2022 16:00:00 GMT
 
PREVIOUS NEXT
Tagged: #Phillips #Evaluates #Therapy #Options #DLBCL #Targeted #Oncology
ADD COMMENT
Topic
Name
5+6 =